KC Entrepreneurship Community Secures Federal Award to Kick-Off $5 Million Pre-Seed Fund

Area organizations collaborated on bi-state economic development proposal to raise and run new, charitable source of early-stage capital FOR IMMEDIATE RELEASE FAIRWAY, Kan. – (October 2, 2017) – The Enterprise Center in Johnson County (ECJC) announced today that it has secured the Economic Development Administration’s  (EDA) Seed Fund Support grant with the cooperation of a bi-state consortium of entrepreneurial and civic leaders. …

Voxello logo

Mid-America Angels invest in medical device startup Voxello

Local angel investors inject $287,000 to help medical device startup grow, shortly prior to receiving news of FDA clearance FAIRWAY, Kan. – (February 20, 2017) – The Mid-America Angels investment network (MAA) announced a $287,000 investment in Voxello, an Iowa-based medical device company. The company’s primary product, called the noddleTM, is a pioneering solution that detects voluntary gestures in hospitalized patients who …

George Hansen

Statement on the appointment of CEO George Hansen to secretary of the Kansas Department of Commerce

The following statement may be attributed to: Melissa Roberts – Marketing Director, Enterprise Center in Johnson County “The Enterprise Center in Johnson County is proud to congratulate CEO George Hansen on his appointment to secretary of the Kansas Department of Commerce and urges the Kansas State Senate to undertake a speedy confirmation process.”

In its 20th year, ECJC makes big changes–inside and out

New brand identity, website and office location will help non-profit enhance capability to serve Kansas City’s entrepreneurial community FAIRWAY, Kan. – (April 30, 2015) – The Enterprise Center in Johnson County (ECJC) revealed its new, updated brand identity and website this morning, following the organization’s relocation to 4220 Shawnee Mission Parkway. The ECJC is a non-profit organization, supported by funds …

Mid-America Angels investment network sets record pace in 2015

LENEXA, Kan. – (April 1, 2015) – The Mid-America Angels investment network (MAA) deployed over $870,000 in commercialization funding in Q1 of 2015. This puts MAA on pace to exceed the $2.3 million members of the network invested in six deals last year. MAA’s Q1 activity included a $696,000 investment in Olathe, Kan.-based TVAX Animal Health and a $178,000 investment, led by …

Mid-America Angels investment network recaps 2014 success

LENEXA, Kan. – (January 26, 2015) – The Mid-America Angels (MAA) marked a successful year in 2014, closing a total of six investments. Since the beginning of last year, the MAA network has provided over $2.3 million in commercialization funding to area startups and high-growth businesses. “We’re consistently thrilled to welcome companies to the MAA portfolio. We look forward to working with …

Mid-America Angels announces 57th investment

Lenexa, Kan. – (August 26, 2014) – The Mid-America Angels (MAA) recently closed a $360,000 investment in ClaimKit LLC, an Overland Park-based claim document management and review software company. The deal was syndicated, with an additional $200,000 investment coming from SeedStep Angels in Oklahoma and included participation from the Women’s Capital Connection. This puts ClaimKit within striking distance of meeting …

Angel Investor Capital Investment Portfolio Company Award

Mid-America Angels portfolio company EyeVerify selected as a winner of the 2014 Angel Capital Association Luis Villalobos Award

Lenexa, KS and Washington, D.C. – (March 28, 2014) – Mid-America Angels (MAA) is pleased to announce EyeVerify, a portfolio company since 2012, has received the 2014 Luis Villalobos Award, presented by the Angel Capital Association (ACA). The winner was announced at an awards dinner during the national ACA Summit in Washington, DC on Thursday, March 27th.

ECJC client ImmunoGenetix announces Richard Ogden, PhD, as new head of Scientific Advisory Board

Lenexa Kan. Dr. Ogden joined Agouron Pharmaceuticals, Inc. as a founding scientist at its inception in 1984, where he held positions of Group Leader of Medicinal Chemistry, Principal Scientist, and Senior Director of Scientific Development. He was a team member in the HIV project which led to the discovery and development of Nelfinavir (Viracept®).